Wortmannin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Wortmannin" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
2nd place
3rd place
5,225th place
2,461st place
924th place
87th place
2,106th place
139th place
low place
low place

clinicaltrials.gov

doi.org

google.de

books.google.de

nih.gov

ncbi.nlm.nih.gov

  • M. P. Wymann, G. Bulgarelli-Leva, M. J. Zvelebil, L. Pirola, B. Vanhaesebroeck, M. D. Waterfield, G. Panayotou: Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. In: Molecular and cellular biology Band 16, Nummer 4, April 1996, S. 1722–1733, PMID 8657148. PMC 231159 (freier Volltext).
  • E. F. Blommaart, U. Krause, J. P. Schellens, H. Vreeling-Sindelárová, A. J. Meijer: The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. In: European Journal of Biochemistry Band 243, Nummer 1–2, Januar 1997, S. 240–246, PMID 9030745.
  • I. Ferby, I. Waga, K. Kume, C. Sakanaka, T. Shimizu: PAF-induced MAPK activation is inhibited by wortmannin in neutrophils and macrophages. In: Advances in Experimental Medicine and Biology Band 416, 1996, S. 321–326, PMID 9131167.
  • I. Vetter, B. D. Wyse, S. J. Roberts-Thomson, G. R. Monteith, P. J. Cabot: Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol. In: European journal of pain (London, England) Band 12, Nummer 4, Mai 2008, S. 441–454, doi:10.1016/j.ejpain.2007.07.001. PMID 17826200.
  • R. Gunther, P. N. Kishore, H. K. Abbas, C. J. Mirocha: Immunosuppressive effects of dietary wortmannin on rats and mice. In: Immunopharmacology and Immunotoxicology Band 11, Nummer 4, 1989, S. 559–570, doi:10.3109/08923978909005385. PMID 2628478.
  • D. Wiesinger, H. U. Gubler, W. Haefliger, D. Hauser: Antiinflammatory activity of the new mould metabolite 11-desacetoxy-wortmannin and of some of its derivatives. In: Experientia Band 30, Nummer 2, Februar 1974, S. 135–136, PMID 4814585.
  • R. A. Smith, H. Yuan, R. Weissleder, L. C. Cantley, L. Josephson: A wortmannin-cetuximab as a double drug. In: Bioconjugate Chemistry Band 20, Nummer 11, November 2009, S. 2185–2189, doi:10.1021/bc900176a. PMID 19883074.
  • H. S. Gwak, T. Shingu, V. Chumbalkar, Y. H. Hwang, R. DeJournett, K. Latha, D. Koul, W. K. Alfred Yung, G. Powis, N. P. Farrell, O. Bögler: Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma. In: International Journal of Cancer. Band 128, Nummer 4, Februar 2011, S. 787–796, doi:10.1002/ijc.25394. PMID 20473884. PMC 299081 (freier Volltext).
  • D. Koul, R. Shen, Y. W. Kim, Y. Kondo, Y. Lu, J. Bankson, S. M. Ronen, D. L. Kirkpatrick, G. Powis, W. K. Yung: Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma. In: Neuro-Oncology Band 12, Nummer 6, Juni 2010, S. 559–569, doi:10.1093/neuonc/nop058. PMID 20156803. PMC 294063 (freier Volltext).

oncothyreon.com

sigmaaldrich.com